Groupama Asset Managment Has $245,000 Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Groupama Asset Managment trimmed its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 83.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,294 shares of the company's stock after selling 31,707 shares during the period. Groupama Asset Managment's holdings in Bath & Body Works were worth $245,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Bath & Body Works by 32.6% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 52,784 shares of the company's stock valued at $2,046,000 after acquiring an additional 12,964 shares during the last quarter. Wellington Management Group LLP bought a new stake in Bath & Body Works during the third quarter valued at $8,129,000. Charles Schwab Investment Management Inc. raised its holdings in shares of Bath & Body Works by 13.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,704,625 shares of the company's stock worth $66,088,000 after purchasing an additional 195,813 shares during the period. New Age Alpha Advisors LLC bought a new position in shares of Bath & Body Works in the 4th quarter worth about $1,350,000. Finally, iA Global Asset Management Inc. boosted its holdings in shares of Bath & Body Works by 1,078.2% in the 3rd quarter. iA Global Asset Management Inc. now owns 49,331 shares of the company's stock valued at $1,575,000 after buying an additional 45,144 shares during the period. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Stock Up 17.8 %

Bath & Body Works stock traded up $4.55 during midday trading on Wednesday, hitting $30.06. The company's stock had a trading volume of 7,945,890 shares, compared to its average volume of 4,627,568. Bath & Body Works, Inc. has a 12 month low of $24.96 and a 12 month high of $52.99. The stock's 50-day moving average price is $33.44 and its 200-day moving average price is $34.03. The company has a market capitalization of $6.44 billion, a PE ratio of 7.33, a price-to-earnings-growth ratio of 0.92 and a beta of 1.69.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.04 by $0.05. The company had revenue of $2.79 billion for the quarter, compared to analysts' expectations of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. As a group, equities analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works declared that its board has approved a stock repurchase plan on Thursday, February 27th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to purchase up to 6.4% of its stock through open market purchases. Stock buyback plans are often an indication that the company's leadership believes its stock is undervalued.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were given a dividend of $0.20 per share. The ex-dividend date was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a yield of 2.66%. Bath & Body Works's payout ratio is presently 21.98%.

Analyst Ratings Changes

Several research firms recently weighed in on BBWI. Argus reiterated a "hold" rating on shares of Bath & Body Works in a research note on Friday, January 10th. Telsey Advisory Group restated an "outperform" rating and set a $43.00 price objective on shares of Bath & Body Works in a research report on Thursday, February 27th. Cowen reaffirmed a "buy" rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Robert W. Baird boosted their price target on shares of Bath & Body Works from $45.00 to $47.00 and gave the company an "outperform" rating in a report on Friday, February 28th. Finally, Citigroup dropped their price objective on shares of Bath & Body Works from $48.00 to $36.00 and set a "buy" rating on the stock in a report on Monday. Four investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, Bath & Body Works has an average rating of "Moderate Buy" and a consensus target price of $44.06.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.